To identify the effect of cytosolic folate disruption in NSCLC cells, three EGFR wild-type NSCLC cell lines—CL1-0, CL1-5, and A549—were cultured in FD medium or treated with the folate antagonist pemetrexed. Here, EGFR is linked to non-small cell lung carcinoma.